Free Trial
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free GMVDF Stock Alerts

G Medical Innovations (GMVDF) Competitors

Compare

GMVDF vs. TTOO, SDCCQ, VRAYQ, AFIB, and UTRS

Should you buy G Medical Innovations stock or one of its competitors? MarketBeat compares G Medical Innovations with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with G Medical Innovations include T2 Biosystems (TTOO), SmileDirectClub (SDCCQ), ViewRay (VRAYQ), Acutus Medical (AFIB), and Minerva Surgical (UTRS). These companies are all part of the "medical equipment" industry.

How does G Medical Innovations compare to T2 Biosystems?

G Medical Innovations (NASDAQ:GMVDF) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation.

G Medical Innovations has a beta of 27.28, indicating that its stock price is 2,628% more volatile than the broader market. Comparatively, T2 Biosystems has a beta of 7.8, indicating that its stock price is 680% more volatile than the broader market.

G Medical Innovations has higher earnings, but lower revenue than T2 Biosystems.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
T2 Biosystems$7.68M0.00-$50.08M-$3.89N/A

6.0% of G Medical Innovations shares are held by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are held by institutional investors. 37.1% of G Medical Innovations shares are held by company insiders. Comparatively, 0.0% of T2 Biosystems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

G Medical Innovations has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
T2 Biosystems -563.16%N/A -174.06%

In the previous week, T2 Biosystems had 1 more articles in the media than G Medical Innovations. MarketBeat recorded 1 mentions for T2 Biosystems and 0 mentions for G Medical Innovations. G Medical Innovations' average media sentiment score of 0.00 equaled T2 Biosystems'average media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
T2 Biosystems Neutral

Summary

G Medical Innovations beats T2 Biosystems on 5 of the 8 factors compared between the two stocks.

How does G Medical Innovations compare to SmileDirectClub?

SmileDirectClub (NASDAQ:SDCCQ) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
SmileDirectClub Neutral
G Medical Innovations Neutral

SmileDirectClub has a beta of 1.35, suggesting that its share price is 35% more volatile than the broader market. Comparatively, G Medical Innovations has a beta of 27.28, suggesting that its share price is 2,628% more volatile than the broader market.

G Medical Innovations has lower revenue, but higher earnings than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.29N/A
G Medical Innovations$4.42M0.00-$24.63MN/AN/A

0.1% of SmileDirectClub shares are held by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are held by institutional investors. 64.7% of SmileDirectClub shares are held by insiders. Comparatively, 37.1% of G Medical Innovations shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
G Medical Innovations N/A N/A N/A

Summary

G Medical Innovations beats SmileDirectClub on 3 of the 5 factors compared between the two stocks.

How does G Medical Innovations compare to ViewRay?

ViewRay (NASDAQ:VRAYQ) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability and media sentiment.

G Medical Innovations has lower revenue, but higher earnings than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ViewRay$102.21M0.00-$107.33M-$0.31N/A
G Medical Innovations$4.42M0.00-$24.63MN/AN/A

15.5% of ViewRay shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 2.5% of ViewRay shares are owned by company insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
ViewRayN/A N/A N/A
G Medical Innovations N/A N/A N/A

In the previous week, ViewRay's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
ViewRay Neutral
G Medical Innovations Neutral

ViewRay has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market. Comparatively, G Medical Innovations has a beta of 27.28, indicating that its share price is 2,628% more volatile than the broader market.

Summary

G Medical Innovations beats ViewRay on 3 of the 5 factors compared between the two stocks.

How does G Medical Innovations compare to Acutus Medical?

Acutus Medical (NASDAQ:AFIB) and G Medical Innovations (NASDAQ:GMVDF) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, risk, earnings, valuation and institutional ownership.

G Medical Innovations has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. G Medical Innovations' return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
G Medical Innovations N/A N/A N/A

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled G Medical Innovations'average media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
G Medical Innovations Neutral

Acutus Medical has a beta of 5.68, meaning that its share price is 468% more volatile than the broader market. Comparatively, G Medical Innovations has a beta of 27.28, meaning that its share price is 2,628% more volatile than the broader market.

56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 6.0% of G Medical Innovations shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by insiders. Comparatively, 37.1% of G Medical Innovations shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

G Medical Innovations has lower revenue, but higher earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
G Medical Innovations$4.42M0.00-$24.63MN/AN/A

Summary

G Medical Innovations beats Acutus Medical on 6 of the 8 factors compared between the two stocks.

How does G Medical Innovations compare to Minerva Surgical?

G Medical Innovations (NASDAQ:GMVDF) and Minerva Surgical (NASDAQ:UTRS) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

G Medical Innovations has higher earnings, but lower revenue than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A

G Medical Innovations has a beta of 27.28, indicating that its share price is 2,628% more volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.92, indicating that its share price is 192% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
Minerva Surgical N/A N/A N/A

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
Minerva Surgical Neutral

6.0% of G Medical Innovations shares are held by institutional investors. 37.1% of G Medical Innovations shares are held by company insiders. Comparatively, 8.5% of Minerva Surgical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

G Medical Innovations beats Minerva Surgical on 4 of the 5 factors compared between the two stocks.

Get G Medical Innovations News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMVDF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GMVDF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GMVDF vs. The Competition

Export
MetricG Medical InnovationsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$26K$39.45M$6.52B$12.05B
Dividend YieldN/A1.08%2.67%5.66%
P/E RatioN/A17.8224.0024.42
Price / SalesN/A27.38515.84118.72
Price / CashN/A18.8627.4837.92
Price / BookN/A12.2810.606.82
Net Income-$24.63M-$16.77M$3.57B$337.56M

G Medical Innovations Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GMVDF
G Medical Innovations
N/AN/AN/AN/A$26K$4.42MN/A72
TTOO
T2 Biosystems
N/A$0.00
flat		N/A-99.7%$42K$7.68MN/A180
SDCCQ
SmileDirectClub
N/AN/AN/AN/A$40K$470.74MN/A2,700
VRAYQ
ViewRay
N/AN/AN/AN/A$18K$102.21MN/A300
AFIB
Acutus Medical
N/A$0.00
-50.0%		N/AN/A$3K$7.16MN/A340

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:GMVDF) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel